Sign in Subscribe

Health

Providing perspective and contextual insights on the monetary aspects of the Healthcare market within the state of Utah, from medical providers to insurance and from nutraceuticals to medical devices.

This Week's $200 Million Investment that Few Utahns Know About has Changed Control of a Pioneering Utah Biotech Firm

This Week's $200 Million Investment that Few Utahns Know About has Changed Control of a Pioneering Utah Biotech Firm

Utah's market-leading Brain-Computer-Interface company, Salt Lake City-based Blackrock Neurotech, has sold controlling interest to Tether for a $200 million investment In news that will shock most executives in Utah's business, life sciences, and technology communities, Salt Lake City-based Blackrock Neurotech has sold controlling interest in its

Kinect Capital Welcomes 23 Presenting Companies to this Week's Investor Choice Conference in Salt Lake City

Kinect Capital Welcomes 23 Presenting Companies to this Week's Investor Choice Conference in Salt Lake City

"According to Kinect Capital, its data says that since 2009 Investors Choice alumni firms have raised over $1.2 billion in investment capital while also achieving financial exits of over $10 billion."

The Property of Five Utah Hospitals has Changed Hands in a Transaction that Values them at Just Under $1.2 Billion

The Property of Five Utah Hospitals has Changed Hands in a Transaction that Values them at Just Under $1.2 Billion

A 75% ownership stake in the real estate of 1) Davis Hospital and Medical Center, 2) Jordan Valley Medical Center, 3) Jordan Valley Medical Center-West Valley Campus, 4) Mountain Point Medical Center, and 5) Salt Lake Regional Medical Center have been sold by Alabama's Medical Properties Trust to

The Underwriters of the PACS Group IPO have Exercised their Option to Purchase ~3.21 Million Shares of Common Stock from the Company's Co-Founders

Yesterday evening, Farmington, Utah-based PACS Group (NYSE:PACS) announced that the underwriters of the company's just completed initial public offering have exercised their 30-day option to purchase ~3.21 million shares of PACS common stock from the firm's co-founders at the offering price of $21.00/

Springville's Medical Marijuana Pharmacy (and its Sister Cultivation Facility) Trade Hands in a $6.5 Million Transaction

Springville's Medical Marijuana Pharmacy (and its Sister Cultivation Facility) Trade Hands in a $6.5 Million Transaction

The Forest Springville carries an impressive depth and breadth of medical cannabis offerings: from dried cannabis flowers to chewable tablets, and from gummies to tinctures, plus a selection of vaporizers, oils and more.

Farmington-based PACS is Poised to Shock Utah's Biz Community with its $3.1 Billion IPO Slated to Hit Today, Thursday, 11 April 2024

Farmington-based PACS is Poised to Shock Utah's Biz Community with its $3.1 Billion IPO Slated to Hit Today, Thursday, 11 April 2024

Following the IPO, PACS will have ~148 million shares of common stock outstanding, giving the Utah-based healthcare provider an anticipated market capitalization of ~$3.1 billion.

Utah-based Clene Lands a $45.1 Million, 4-Year NIH Grant that Expands Access to its ALS Drug Candidate: CNM-Au8®

Awarded in partnership with Columbia University and Synapticure, this grant provides a pathway for patients with Lou Gehrig's Disease to pursue "Compassionate Use" participation in a new Expanded Access Protocol (EAP) treatment program with Clene as amyotrophic lateral sclerosis (ALS) sufferers. In major drug discovery news